About Us
We are the global leaders in regenerative solutions. Our bioresorbable implant is the first of its kind to be successfully developed and commercialized for surgical use.
Our implants heal bone naturally. They are made of a bioresorbable polymer that dissolves over time, leaving only natural, healthy bone. This reduces post-surgery complication rates significantly, compared to permanent implants.
Our products are trusted and used by surgeons across Asia, Europe, Australia, and the Americas.
Awards & Recognitions
Brands for Good, Distinction Award for Leadership for Good
RHOTO Award - Tech Planter Singapore 2023
Industry Partner Recognition Award JOINT LAB
Leave A Nest Group CEO Award
T-Up Eagles Award 2022 - Certificate of Recognition
Made in Singapore Award for Medical 2020 - Singapore Business Review
Expanding Global Presence
We are approved for use across several regions and operate in over 20 countries and autonomous regions.
Featured Clinical Applications
Craniotomy
Our Osteoplug in plug and strip configuration fill craniotomy gaps effortlessly. They also promote bone tissue integration, from the skull to the bone flap.
Skull Base Closure
With a one-step process, Osteopore's mesh products may support the reconstruction of the skull base entry. The regenerative scaffold fully resorbs by hydrolysis in 18-24 months leaving only natural bone.
Our Technology
We harness the body’s regenerative capacity to rebuild lost tissues. Osteopore (OSX) creates bioresorbable implants by leveraging the combined technologies of tissue engineering, regenerative medicine, and 3d printing techniques.
With in-situ tissue engineering, surgeons and dentists reduce time to treatment—there is no need for them to extensively manipulate or culture cells and material outside of the body.
Quality Systems
EN ISO 13485
USFDA QSR-21 CFR Part 820
USFDA QSR-21 CFR Part 820
Regulatory Compliances
We strive to be a World Leader in Bioresorbable Scaffold Tissue Engineering by using Cutting-Edge Technology. We want to bring "A Message of Hope in Restoring Tissue to Normality" through the development of new scaffolds technologies and manufacturing medical devices which will repair and regenerate tissue that is both safe and effective while complying with all regulatory requirements for use.